Effect of a hydrogen (H2)-enriched solution on the albumin redox of hemodialysis patients.
Hiroyuki Terawaki, Wan-Jun Zhu, Yukie Matsuyama, Tomoyoshi Terada, Yasuhito Takahashi, Kaoru Sakurai, Shigeru Kabayama, Mariko Miyazaki, Noritomo Itami, Ryoichi Nakazawa, Sadayoshi Ito, Seiichi Era, Masaaki Nakayama · Hemodialysis international. International Symposium on Home Hemodialysis · 2014
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In 8 patients, however, the mean proportion of reversibly oxidized albumin in outlet serum was significantly lower than that in inlet serum following the H₂-HD session, whereas no significant changes were found in the standard solution session, suggesting that "intra-dialyzer" OS is reduced by H₂ -HD. These findings add human evidence supporting molecular hydrogen's therapeutic potential across the specific human outcomes evaluated in this study. This human hemodialysis study evaluated an H₂-enriched solution. Redox or peroxide terminology describes the biological context and does not change the identity of the molecular-hydrogen intervention.
What Effects Did Molecular Hydrogen Have?
In 8 patients, however, the mean proportion of reversibly oxidized albumin in outlet serum was significantly lower than that in inlet serum following the H₂-HD session, whereas no significant changes were found in the standard solution session, suggesting that "intra-dialyzer" OS is reduced by H₂ -HD. The authors concluded that in conclusion, the application of H₂-enriched solutions could ameliorate OS during HD.
What the Findings Mean
H2HUBB reviewed how molecular hydrogen affected the outcomes measured in 8 patients. However, the mean proportion of reversibly oxidized albumin in outlet serum was significantly lower than that in inlet serum following the H₂-HD session, whereas no significant changes were found in the standard solution session, suggesting that "intra-dialyzer" OS is reduced by H₂ -HD.
What the Researchers Studied
The researchers studied 8 patients. The study used a human clinical study.
Why These Findings Matter
These findings add human evidence supporting molecular hydrogen's therapeutic potential across the specific human outcomes evaluated in this study and contribute to the growing body of molecular-hydrogen research.
How Strong Is This Evidence?
This is human clinical evidence from a human clinical study. H2HUBB interprets the findings in the context of the study design, sample, comparator, and measured outcomes rather than using one publication as a verdict on hydrogen therapy.
Technical Study Details
H2HUBB classifies this publication as human clinical study with human clinical evidence. The research population or model was 8 patients. The reported sample size was 8. The study used a human clinical study.
Limitations and Safety
No separate limitations or safety findings were identified in the current-study source text available to H2HUBB. This human hemodialysis study evaluated an H₂-enriched solution. Redox or peroxide terminology describes the biological context and does not change the identity of the molecular-hydrogen intervention.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.